Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurofilament Light Chain and Cognitive Impairment as Diagnostic and Prognostic Markers in naïve Multiple Sclerosis Patients

NCT06197841 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT06197841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06197841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurofilament Light Chain and Cognitive Impairment as Diagnostic and Prognostic Markers in naïve Multiple Sclerosis Patients
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2023
Completion date
December 31, 2024
Enrollment
85 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

role of neurofilment in diagnosis of multiple sclerosis